These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 1252788)

  • 1. Letter: Trental and peripheral vascular disease.
    Barnes AJ
    Br Med J; 1976 Feb; 1(6007):455. PubMed ID: 1252788
    [No Abstract]   [Full Text] [Related]  

  • 2. [Experiences with the new vasotherapeutic drug Trental in dermatology].
    Herger R
    Fortschr Med; 1972 Aug; 90(24):865-72. PubMed ID: 4639351
    [No Abstract]   [Full Text] [Related]  

  • 3. [On the therapy of central and peripheral blood circulation disorders].
    Weihrauch H
    Hippokrates; 1967 Sep; 38(18):739-42. PubMed ID: 5610064
    [No Abstract]   [Full Text] [Related]  

  • 4. Cosaldon for vascular disorders?
    Drug Ther Bull; 1972 Aug; 10(17):66-8. PubMed ID: 4570865
    [No Abstract]   [Full Text] [Related]  

  • 5. Trials of 3,7-dimethyl-1-(5-oxohexyl) xanthine (BL 191) in double-blind tests.
    Buckert D; Harwart D
    Farmaco Prat; 1976 May; 31(5):264-74. PubMed ID: 773679
    [No Abstract]   [Full Text] [Related]  

  • 6. [Clinical trials with xanthinol niacinate in angiological therapy].
    García Zozaya R
    Rev Clin Esp; 1966 Mar; 100(5):347-53. PubMed ID: 5937752
    [No Abstract]   [Full Text] [Related]  

  • 7. [Results of a clinical study on the vasodilator 3,7-dimethyl-1-(5-oxo-hexyl)-xanthine (BL 191)].
    Lehrach F; Müller R
    Arzneimittelforschung; 1971 Aug; 21(8):1171-4. PubMed ID: 5110012
    [No Abstract]   [Full Text] [Related]  

  • 8. [Value of drugs acting on the smooth musculature by direct and indirect routes in therapy of vascular diseases].
    Labò G; Pretolani E
    Cardiol Prat; 1971 Feb; 22(1):1-9. PubMed ID: 4398064
    [No Abstract]   [Full Text] [Related]  

  • 9. [Principal vascular diseases as reflected in the fundus oculi].
    Honti G
    Bull Mem Soc Fr Ophtalmol; 1966; 79():503-5. PubMed ID: 6015407
    [No Abstract]   [Full Text] [Related]  

  • 10. Oxpentifylline (Trental) in peripheral arterial disease.
    Drug Ther Bull; 1976 Jul; 14(15):59-60. PubMed ID: 964131
    [No Abstract]   [Full Text] [Related]  

  • 11. [Assessment of the therapeutic effect of Trental 400. Double-blind study in geriatric patients with circulatory disorders].
    Feine-Haake G
    Fortschr Med; 1977 Jan; 95(1):48-51. PubMed ID: 401759
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Experiences with Trental in peripheral circulatory disorders and cerebrovascular insufficiency (author's transl)].
    Schafé MK
    Munch Med Wochenschr; 1973 Oct; 115(40):1745-9. PubMed ID: 4801042
    [No Abstract]   [Full Text] [Related]  

  • 13. [Demonstration of the effect of pentoxyphylline in arterial circulation disorders (double-blind study using Trental 400)].
    Schubotz R
    Med Welt; 1975 Oct; 26(41):1884-5. PubMed ID: 1196082
    [No Abstract]   [Full Text] [Related]  

  • 14. [Treatment of peripheral occlusive vascular disease with pentoxifylin (author's transl)].
    Traumann KJ
    Med Klin; 1976 Mar; 71(11):465-8. PubMed ID: 1263995
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Use of Trental in the treatment of arterial and venous circulation disorders].
    Grujić M; Obradov S; Perinović M; Rizvanbegović B
    Med Arh; 1976; 30(5):327-30. PubMed ID: 798077
    [No Abstract]   [Full Text] [Related]  

  • 16. Hemorheology and peripheral vascular diseases: a new therapeutic approach.
    Müller R
    J Med; 1981; 12(4):209-35. PubMed ID: 7031157
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Letter: Assessment of advertising.
    Wigle WW
    Can Med Assoc J; 1974 Apr; 110(7):759. PubMed ID: 4825144
    [No Abstract]   [Full Text] [Related]  

  • 18. Letter: Misleading drug advertising.
    Jouhar AJ
    Br Med J; 1975 Apr; 2(5961):38. PubMed ID: 1137785
    [No Abstract]   [Full Text] [Related]  

  • 19. [Therapeutic methods with a new xanthine derivative in peripheral and central circulatory disorders].
    Mansfeld HG
    Dtsch Med J; 1972 Jan; 23(1):49-53. PubMed ID: 5060262
    [No Abstract]   [Full Text] [Related]  

  • 20. [OPEN LETTER TO THE DIRECTOR OF A PHARMACEUTICAL LABORATORY].
    GOMEZCEBALLOS J
    Folia Clin Int (Barc); 1964 Jan; 14():50-2. PubMed ID: 14127475
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.